BIOIF (BIOIF) Stock Price & Analysis
BIOIF (BIOIF) rose 0.00% to USD 0 as of June 10, 2026 at 11:09 UTC, according to Nexqual real-time market data.
BIOIF last closed at USD 0; the session ranged USD 0–0 on volume of 9,000 shares. Market capitalization is $56,208, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 11:09 UTC.
Key Statistics (as of June 10, 2026 at 11:09 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 9,000 shares |
| Market Cap | $56,208 |
| Exchange | PNK |
Technical Analysis (BIOIF)
Nexqual's technical model rates BIOIF "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 11:09 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (BIOIF)
Wall Street analysts rate BIOIF "None", per Nexqual as of June 10, 2026 at 11:09 UTC.
| Consensus Rating | None |
|---|
Earnings (BIOIF)
Source: Nexqual, June 10, 2026 at 11:09 UTC.
Financials & Fundamentals (BIOIF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.03 |
| Total Cash | $56,364 |
| Total Debt | $4.18M |
| Free Cash Flow | $-215,380 |
Source: Nexqual, June 10, 2026 at 11:09 UTC.
Financial Health Score (BIOIF)
Nexqual rates BIOIF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 11:09 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $56K cash vs $4M debt |
| Cash Flow | Weak — FCF negative: -$215K, burning cash |
| Efficiency | Mixed — No data |
Ownership (BIOIF)
| Insider Ownership | +47.31% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 112.42M |
Source: Nexqual, June 10, 2026 at 11:09 UTC.
Leadership (BIOIF)
BIOIF is led by Khurram Malik, CEO, President, Director & Interim CFO, per Nexqual as of June 10, 2026 at 11:09 UTC.
| CEO, President, Director & Interim CFO | Khurram Malik |
|---|---|
| President of Highland Grow Inc. | Frank MacMaster |
| President of The Back Home Medical Cannabis Corporation | David Callahan |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CHMJF | CHEMISTREE TECHNOLOGY INC | USD 0.1 | ▲ 322.61% |
| INLB | ITEM 9 LABS CORP | USD 0 | ▲ 0% |
| BBRRF | Blueberries Medical Co. | USD 0.01 | ▼ 16.41% |
| MJARF | MJARDIN GROUP INC | USD 0 | ▲ 0% |
| SRUTF | SPROUTLY CANADA INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 11:09 UTC. This page is informational and not investment advice.